Karen GilchristSkip NavigationMarketsPre-MarketsU.S. MarketsCurrenciesCryptocurrencyFutures & CommoditiesBondsFunds & ETFsBusinessEconomyFinanceHealth & ScienceMediaReal EstateEnergyClimateTransportationIndustrialsRetailWealthSportsLifeSmall BusinessInvestingPersonal FinanceFintechFinancial AdvisorsOptions ActionETF StreetBuffett ArchiveEarningsTrader TalkTechCybersecurityAIEnterpriseInternetMediaMobileSocial MediaCNBC Disruptor 50Tech GuidePoliticsWhite HousePolicyDefenseCongressExpanding OpportunityVideoLatest VideoFull EpisodesLivestreamLive AudioLive TV ScheduleCNBC PodcastsCEO InterviewsCNBC DocumentariesDigital OriginalsWatchlistInvesting ClubTrust PortfolioAnalysisTrade AlertsMeeting VideosHomestretchJim's ColumnsEducationSubscribePROPro NewsJosh BrownNEW!My PortfolioLivestreamFull EpisodesStock ScreenerMarket ForecastOptions InvestingChart InvestingStock ListsSubscribeLivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free accountMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenuKaren GilchristCorrespondentKaren Gilchrist is a Correspondent for CNBC in London, covering breaking news, international politics and financial markets, with a particular focus on the luxury, retail, pharmaceutical and real estate sectors.read moreLatestwatch nowVIDEO01:07H&M flags tariff impact and potential U.S. price hikes to comeKaren Gilchrist10 Hours AgoH&M shares jump 8% on third-quarter sales beat as turnaround takes paceKaren Gilchrist17 Hours AgoRoche targets becoming top 3 obesity player as experimental drug enters late-stage trialKaren Gilchrist19 Hours AgoNovo Nordisk shares pop 5% after Wegovy pill trial shows 'significant' weight reductionKaren GilchristSeptember 18, 2025Ben & Jerry's co-founder Jerry Greenfield quits over social activism row with UnileverKaren GilchristSeptember 17, 2025UK's GSK announces $30 billion U.S. pharma investment amid Trump state visitKaren GilchristSeptember 17, 2025Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbusterKaren GilchristSeptember 16, 2025Pharma firms pile pressure on the UK as Trump's drug pricing order loomsKaren GilchristSeptember 16, 2025S&P 500 eases a bit from record as traders await big Fed rate decisionPia Singh|Alex HarringSeptember 15, 2025Swatch takes a swipe at Trump’s 39% tariff with switched-up watchKaren GilchristSeptember 12, 2025Luxury brands bet on $160 lipsticks and $1,400 accessories to combat industry slumpKaren GilchristSeptember 11, 2025Novo Nordisk job cuts a necessary reset after hypergrowth, analysts say Karen GilchristSeptember 10, 2025Load MoreSubscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsSelect Personal FinanceCNBC on PeacockJoin the CNBC PanelSupply Chain ValuesClosed CaptioningDigital ProductsNews ReleasesInternshipsCorrectionsAbout CNBCAd ChoicesSite MapPodcastsCareersHelpContactNews TipsGot a confidential news tip? We want to hear from you.Get In TouchCNBC NewslettersSign up for free newsletters and get more CNBC delivered to your inboxSign Up NowGet this delivered to your inbox, and more info about our products and services.Advertise With UsPlease Contact UsPrivacy PolicyCA NoticeTerms of Service© 2025 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes.
Global Business and Financial News, Stock Quotes, and Market Data
and Analysis.
Market Data Terms of Use and DisclaimersData also provided by